Prostate-specific antigen testing in older men in the USA: Data from the behavioral risk factor surveillance system

BJU International

Volumn 110, Issue 10, 2012, Pages 1485-1490

  Scosyrev, Emil ^a   Wu, Guan ^a   Golijanin, Dragan ^a   Messing, Edward ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Behavioral Risk Factor Surveillance System; BRFSS; prostate cancer; PSA

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGE; AGED; ARTICLE; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; BODY MASS; CANCER SCREENING; CARDIOVASCULAR DISEASE; COMORBIDITY; EDUCATIONAL STATUS; HUMAN; MALE; MARRIED MAN; PRIORITY JOURNAL; PROSTATE CANCER; SMOKING; UNITED STATES;

AGED; AGED, 80 AND OVER; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; GUIDELINE ADHERENCE; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; UNITED STATES;

EID: 84868195676     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11013.x     Document Type: Article

References (20)

1. Jemal A, Siegel R, Xu J, Ward E,. Cancer statistics 2010. CA Cancer J Clin 2010; 60: 277-300
2. Schröder FH, Hugosson J, Roobol MJ, et al,. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009; 360: 1320-8
3. Sandblom G, Varenhorst E, Rosell J, Löfman O, Carlsson P,. Randomized prostate cancer screening trial: 20 years follow-up. BMJ 2011; 31: 342:d1539. doi:10.1136/bmj.d1539
4. Andriole GL, Crawford D, Grubb RL, et al,. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 2009; 360: 1310-9
5. Crawford ED, Grubb R 3rd, Black A, et al,. Comorbidity and mortality results from a randomized prostate cancer screening trial. J Clin Oncol 2011; 29: 355-61
6. US Preventive Services Task Force. Screening for prostate cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 2008; 149: 185-91
7. Hoffman KE, Nguyen PL, Ng KA, D'Amico AV,. Prostate cancer screening in men 75 years old or older: an assessment of self-reported health status and life expectancy. J Urol 2010; 183: 1798-802
8. Drazer MW, Huo D, Schonberg MA, Razmaria A, Eggener SE,. Population-based patterns and predictors of prostate-specific antigen screening among older men in the United States. J Clin Oncol 2011; 29: 1736-43
9. Centers for Disease Control and Prevention. Behavioral risk factor surveillance system. Available at: http://www.cdc.gov/BRFSS/. Accessed June 2011
10. SAS Institute. SAS/STAT User's Guide, Second Edition: SURVEYFREQ Procedure. 2010. Available at: http://support.sas.com/documentation/cdl/en/ statug/63033/HTML/default/viewer.htm#statug-surveyfreq-sect001.htm. Accessed June 2011
11. SAS Institute. SAS/STAT User's Guide, Second Edition: SURVEYLOGISTIC Procedure. 2010. Available at: http://support.sas.com/documentation/cdl/en/ statug/63033/HTML/default/viewer.htm#surveylogistic-toc.htm. Accessed June 2011
12. Kawachi MH, Babaian RJ, Bahnson RR, et al,. NCCN clinical practice guidelines in oncology: prostate cancer early detection. Version 2.2010. 2010
13. Greene KL, Albertsen PC, Babaian RJ, et al,. Prostate specific antigen best practice statement: 2009 update. J Urol 2009; 182: 2232-41
14. Wolf AM, Wender RC, Etzioni RB, et al,. American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin 2010; 60: 70-98
15. Walter LC, Covinsky KE,. Cancer screening in elderly patients: a framework for individualized decision making. JAMA 2001; 285: 2750-56 (Pubitemid 32525372)
16. Department of Health and Human Services, Health Care Financing Administration. Department of health and human services, health care financing administration: medicare intermediary manual part 3-claims process. 2000
17. Cabana MD, Rand CS, Powe NR, et al,. Why don't physicians follow clinical practice guidelines? JAMA 1999; 282: 1458-65
18. Li J, Zhao G, Pollack LA, Smith JL, Joseph DA,. Use of the prostate-specific antigen test among men aged 75 years old or older in the United States: 2006 Behavioral Risk Factor Surveillance System. Prev Chronic Dis 2010; 7: 1-8
19. Zeliadt SB, Hoffman RM, Etzioni R, Gore LJ, Kessler LG, Lin DW,. Influence of publication of US and European prostate cancer screening trials on PSA testing practices. J Natl Cancer Inst 2011; 103: 520-3
20. Kadiyala S,. Are US cancer screening test patterns consistent with guideline recommendations with respect to age of screening initiation? BMC Health Serv Res 2009; 9: 185-94